Compare AWR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWR | DYN |
|---|---|---|
| Founded | 1929 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 1998 | 2020 |
| Metric | AWR | DYN |
|---|---|---|
| Price | $72.80 | $18.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $84.00 | $37.00 |
| AVG Volume (30 Days) | 202.2K | ★ 2.1M |
| Earning Date | 05-06-2026 | 03-02-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ 6.31 | N/A |
| EPS | ★ 3.37 | N/A |
| Revenue | ★ $658,073,000.00 | N/A |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | $21.60 | ★ N/A |
| Revenue Growth | ★ 10.52 | N/A |
| 52 Week Low | $69.45 | $7.01 |
| 52 Week High | $82.94 | $25.00 |
| Indicator | AWR | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 56.92 |
| Support Level | $71.14 | $18.32 |
| Resistance Level | $74.78 | $20.08 |
| Average True Range (ATR) | 1.56 | 1.24 |
| MACD | -0.20 | 0.33 |
| Stochastic Oscillator | 12.19 | 72.80 |
American States Water Co is a water and utilities holding company based in California. The segments of the firm include water, electric, and contracted services. Within these segments, American States Water conducts water and electric operations through Golden State Water Company and Bear Valley Electric Service, Inc while contracted services through American States Utility Services and its subsidiaries. Golden State Water conducts its operations across various counties in California and is regulated by the California Public Utilities Commission. American States Utility Services has contracted with the U.S. government to provide water services to various military installations. The majority of the company's revenue is derived from water services to commercial and residential customers.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.